In a blow to Teva, US approves competitor's drugMylan NV received the green light to produce a copycat version of Teva’s blockbuster drug, Copaxone, which is already on its way to American patients.A building in Jerusalem belonging to generic drug producer Teva(photo credit: REUTERS/BAZ RATNER)
